← Eichor
Condition: Active Ulcerative Colitis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Active Ulcerative Colitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Confirmatory Clinical Study in Active Ulcerative Colitis
Phase 2 · 16 location(s) · MRM Health NV · NCT07296315The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC
Phase 2 · 1 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT07507513Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Phase N/A · 12 location(s) · TIDHI Innovation Inc. · NCT07245394A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
Phase N/A · 38 location(s) · Pfizer · NCT06294925An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cy
Phase 1 · 7 location(s) · Hoffmann-La Roche · NCT07665723R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Phase 1 · 5 location(s) · Rise Therapeutics LLC · NCT05666960LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Phase 2 · 147 location(s) · Eli Lilly and Company · NCT07186101A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Phase 2 · 45 location(s) · Pfizer · NCT05287126Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)
Phase N/A · 1 location(s) · Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di · NCT07670975Superdonor FMT in Patients With Ulcerative Colitis
Phase 1/Phase 2 · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05739864A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Phase 2 · 25 location(s) · Pfizer · NCT07470879Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Col
Phase 1 · 30 location(s) · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06754891Analysis of Barriers and Facilitators to Adapted Physical Activity for Pediatric Patients With Chronic Inflammatory Bowe
Phase N/A · 1 location(s) · Fondation Lenval · NCT07383844Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subject
Phase 4 · 4 location(s) · Bausch Health Americas, Inc. · NCT04314375Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopea
Phase N/A · 1 location(s) · Imelda GI Clinical Research Center · NCT07621783A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
Phase 1/Phase 2 · 1 location(s) · Mage Biologics · NCT07374471A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
Phase 4 · 101 location(s) · Takeda · NCT06581328Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (UC)
NA · 1 location(s) · Biao Zou · NCT05679622A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Phase 2 · 259 location(s) · Spyre Therapeutics, Inc. · NCT07012395Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
Phase 2 · 1 location(s) · Medical University of Lodz · NCT06453317A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagno
NA · 6 location(s) · All India Institute of Medical Sciences · NCT06895252Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NA · 1 location(s) · Central Hospital, Nancy, France · NCT05733845A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inf
Phase 2 · 1 location(s) · Shandong Suncadia Medicine Co., Ltd. · NCT07229950A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · 47 location(s) · Alfasigma S.p.A. · NCT06865417A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Col
Phase 3 · 398 location(s) · Janssen Research & Development, LLC · NCT07196748A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Phase 2 · 207 location(s) · Eli Lilly and Company · NCT06598943A Study for HSK47388 in Participants With Ulcerative Colitis
Phase 2 · 1 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT07335055Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcer
Phase N/A · 56 location(s) · AbbVie · NCT06764706Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Phase 1/Phase 2 · 90 location(s) · Xencor, Inc. · NCT06619990A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Phase 2 · 66 location(s) · Mirador Therapeutics, Inc. · NCT07113522
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.